CoreCap Advisors’s Cellebrite CLBT Stock Holding History

CoreCap Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33.6K	Hold	2,980	–	–	﹤0.01%	1582
2026 Q2	$43.5K	Hold	2,980	–	–	﹤0.01%	1466
2026 Q1	$41.1K	Hold	2,980	–	–	﹤0.01%	1390
2025 Q4	$53.7K	Hold	2,980	–	–	﹤0.01%	1302
2025 Q3	$55.2K	Hold	2,980	–	–	﹤0.01%	1276
2025 Q2	$47.7K	Buy	2,980 +880	+42%	+$15.7K	﹤0.01%	1280
2025 Q1	$40.8K	Hold	2,100	–	–	﹤0.01%	1257
2024 Q4	$46.3K	Hold	2,100	–	–	﹤0.01%	1212
2024 Q3	$35.4K	Hold	2,100	–	–	﹤0.01%	1334
2024 Q2	$25.1K	Buy	+2,100	New	+$23.5K	﹤0.01%	835

Other funds holding CLBT

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

CoreCap Advisors's CLBT Position: Q3 2026 in Review

CoreCap Advisors held its Cellebrite (CLBT) position steady in Q3 2026 at 2,980 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

CoreCap Advisors first reported a position in CLBT in Q2 2024 and has held it in 10 quarters since. The position peaked at $55.2K in Q3 2025. 5 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

CoreCap Advisors held 2,980 shares of Cellebrite worth $33.6K as of Q3 2026.
CoreCap Advisors left its Cellebrite share count unchanged in Q3 2026.
Cellebrite made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1582 holding.
CoreCap Advisors first reported a position in Cellebrite in Q2 2024 and has held it in 10 quarters since.
CoreCap Advisors's Cellebrite position peaked at $55.2K in Q3 2025.
5 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.